PIK3CA and neoplasm: Further, PIK3CA mutations, frequently detected in cfDNA in breast cancer and an indicator of tumour burden and treatment efficacy have been a subject of interest [45,46,47,48] since they also show high concordance between cfDNA and metastatic tumours [49].